| Ticker Details |
Merck & Co., Inc.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$302.33B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.56 | 0.90%
|
| Avg Daily Range (30 D): |
$1.41 | 1.23%
|
| Avg Daily Range (90 D): |
$1.27 | 1.10%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
10.51M |
| Avg Daily Volume (30 D): |
6.74M |
| Avg Daily Volume (90 D): |
7.92M |
| Trade Size |
| Avg Trade Size (Sh.): |
168 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
63 |
| Institutional Trades |
| Total Institutional Trades: |
175,329 |
| Avg Institutional Trade: |
$5.91M |
| Avg Institutional Trade (30 D): |
$14.56M |
| Avg Institutional Trade (90 D): |
$15.75M |
| Avg Institutional Trade Volume: |
.1M |
| Avg Institutional Trades (Per Day): |
30 |
| Market Closing Trades |
| Avg Closing Trade: |
$85.89M |
| Avg Closing Trade (30 D): |
$189.85M |
| Avg Closing Trade (90 D): |
$216.73M |
| Avg Closing Volume: |
1.15M |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$3.57
|
$-1.72
|
$1.21
|
|
Diluted EPS
|
$3.56
|
$-1.72
|
$1.2
|
|
Revenue
|
$65.77B
|
$16.29B
|
$16.4B
|
|
Gross Profit
|
$48.61B
|
$12.09B
|
$10.85B
|
|
Net Income / Loss
|
$8.93B
|
$-4243M
|
$2.96B
|
|
Operating Income / Loss
|
$11.63B
|
$-3534M
|
$3.42B
|
|
Cost of Revenue
|
$17.16B
|
$4.2B
|
$5.55B
|
|
Net Cash Flow
|
$-3334M
|
$-9292M
|
$-3570M
|
|
PE Ratio
|
|
|
|
|
|
|